Published in Biochem J on June 15, 2012
Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J (2015) 1.12
Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol (2013) 1.06
New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3. Biosci Rep (2014) 0.96
Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands. Front Immunol (2014) 0.85
Properdin: a tightly regulated critical inflammatory modulator. Immunol Rev (2016) 0.85
Zinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration. J Biol Chem (2013) 0.82
Multifunctional silk-heparin biomaterials for vascular tissue engineering applications. Biomaterials (2013) 0.80
The solution structure of heparan sulfate differs from that of heparin: implications for function. J Biol Chem (2013) 0.80
Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus. PLoS One (2012) 0.78
Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology (2003) 2.37
Glycolipids as receptors for Bacillus thuringiensis crystal toxin. Science (2005) 2.05
His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 1.79
Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling. Structure (2012) 1.68
Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions. J Am Soc Nephrol (2005) 1.62
Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood (2002) 1.62
Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation. J Biol Chem (2009) 1.60
The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models. Hum Mutat (2007) 1.59
VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem (2005) 1.53
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem J (2010) 1.45
Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions. Chem Biol (2007) 1.42
A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med (2008) 1.30
An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation. J Biol Chem (2006) 1.24
Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem (2001) 1.22
Protein disorder: conformational distribution of the flexible linker in a chimeric double cellulase. Biophys J (2005) 1.22
Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1. J Mol Biol (2004) 1.17
Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE. J Pharm Sci (2009) 1.16
Distinct roles of doublecortin modulating the microtubule cytoskeleton. EMBO J (2006) 1.16
Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments. J Biol Chem (2005) 1.16
An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat (2006) 1.16
Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem (2009) 1.15
Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex. J Mol Biol (2004) 1.14
The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J Mol Biol (2007) 1.14
Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy. Biochemistry (2006) 1.12
The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling. J Mol Biol (2004) 1.09
Isolation and partial characterization of fucan sulfates from the body wall of sea cucumber Stichopus japonicus and their ability to inhibit osteoclastogenesis. Carbohydr Res (2004) 1.09
Analytical ultracentrifugation combined with X-ray and neutron scattering: Experiment and modelling. Methods (2011) 1.09
Heparin and low-molecular-weight heparin. Thromb Haemost (2008) 1.08
Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. J Biol Chem (2010) 1.07
Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. J Mol Biol (2005) 1.07
Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy. J Immunol (2008) 1.06
Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol (2013) 1.06
Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J Mol Biol (2009) 1.05
Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology (2008) 1.01
Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. Immunobiology (2011) 1.01
Electrostatic interactions contribute to the folded-back conformation of wild type human factor H. J Mol Biol (2009) 1.00
Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin. J Biol Chem (2002) 1.00
A method for the non-covalent immobilization of heparin to surfaces. Anal Biochem (2004) 1.00
Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J Mol Biol (2007) 1.00
The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. J Mol Biol (2006) 0.99
The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses. J Biol Chem (2008) 0.99
Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3. Biochem J (2010) 0.98
Solution structure of human secretory component and implications for biological function. J Biol Chem (2007) 0.98
Two distinct sites in sonic Hedgehog combine for heparan sulfate interactions and cell signaling functions. J Biol Chem (2011) 0.98
Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights. J R Soc Interface (2009) 0.97
The anticoagulant and antithrombotic mechanisms of heparin. Handb Exp Pharmacol (2012) 0.96
Structure, stability and dynamics of the central domain of cardiac myosin binding protein C (MyBP-C): implications for multidomain assembly and causes for cardiomyopathy. J Mol Biol (2003) 0.96
The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1. Glycobiology (2003) 0.96
Investigation of the self-association and hetero-association interactions of H-NS and StpA from Enterobacteria. Mol Microbiol (2009) 0.95
Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling. J Mol Biol (2005) 0.95
The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. J Mol Biol (2007) 0.94
Oligomeric assembly and interactions within the human RuvB-like RuvBL1 and RuvBL2 complexes. Biochem J (2010) 0.94
Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions. Glycobiology (2009) 0.93
Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4. Mol Immunol (2009) 0.93
Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J Mol Biol (2002) 0.93
Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering. J Mol Biol (2005) 0.92
Solution structure of the complex formed between human complement C3d and full-length complement receptor type 2. J Mol Biol (2008) 0.92
Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy. Biochem J (2010) 0.91
An unfractionated fucoidan from Ascophyllum nodosum: extraction, characterization, and apoptotic effects in vitro. J Nat Prod (2011) 0.90
Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease. J Mol Biol (2008) 0.90
Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood (2002) 0.90
Carbohydrates and glycoconjugates. Glycomics: the new era of carbohydrate biology. Curr Opin Struct Biol (2003) 0.90
Multiple interactions of complement Factor H with its ligands in solution: a progress report. Adv Exp Med Biol (2010) 0.89
C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer. J Biol Chem (2009) 0.89
Implications of the progressive self-association of wild-type human factor H for complement regulation and disease. J Mol Biol (2007) 0.88
Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex. Biochem J (2012) 0.87
Retracted The solution structure of heparan sulfate differs from that of heparin: implications for function. J Biol Chem (2011) 0.87
CoagMDB: a database analysis of missense mutations within four conserved domains in five vitamin K-dependent coagulation serine proteases using a text-mining tool. Hum Mutat (2008) 0.87
Analysis of chain and blood group type and branching pattern of sialylated oligosaccharides by negative ion electrospray tandem mass spectrometry. Anal Chem (2006) 0.86
The solution structure of rabbit IgG accounts for its interactions with the Fc receptor and complement C1q and its conformational stability. J Mol Biol (2012) 0.86
Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration. J Mol Biol (2011) 0.86
The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells. Thromb Haemost (2002) 0.85
Prospects for glycoinformatics. Curr Opin Struct Biol (2005) 0.85
Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy. J Mol Biol (2005) 0.85
Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness. Am J Kidney Dis (2008) 0.85
Structures of the O-linked oligosaccharides of a complex glycoconjugate from Pseudallescheria boydii. Glycobiology (2005) 0.84
Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol (2002) 0.84
Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation. J Mol Biol (2009) 0.84
Partial purification and chemical characterization of a glycoprotein (putative hydrocolloid) emulsifier produced by a marine bacterium Antarctobacter. Appl Microbiol Biotechnol (2007) 0.84